News

  • LABATEC Women Health and Mithra announce the successful launch of Myloop® in Switzerland

    9 June 2021

    LABATEC WOMEN HEALTH AND MITHRA ANNOUNCE THE SUCCESSFUL LAUNCH OF MYLOOP® IN SWITZERLAND A hormonal contraceptive ring   Geneva, 10th of June 2021 – LABATEC successfully launches a contraceptive vaginal ring – MyLoop® manufactured by our partner Mithra. About MyLoop® This contraceptive vaginal ring is a generic of NuvaRing®. This medicine will be marketed as MyLoop®, […]

  • Swissmedic approves Intrarosa® (prasterone) for the treatment of vulvovaginal atrophy in postmenopausal women

    3 June 2020

    Swissmedic approves Intrarosa® (prasterone) for the treatment of vulvovaginal atrophy in postmenopausal women A novel drug for the treatment of vulvovaginal atrophy based on prasterone (DHEA)   Geneva, the 02.06.2020 – On 19.05.2020, Swissmedic, the Swiss Agency for Therapeutic Products, granted a marketing authorization for the active substance prasterone for the local treatment of vulvovaginal […]


Medical Congresses & Conferences

  • 24-25
    June
    2021

    KHM congress

    Luzern, Switzerland

  • 24-26
    June
    2021

    Congrès annuel de Gynecologie

    Interlaken, Switzerland

  • 29-01
    October
    2021

    Congrès annuel société suisse d’Urologie

    Interlaken, Switzerland

  • 25-27
    November
    2021

    SAMM (Manual Medicine Swiss Society Congress)

    Interlaken, Switzerland

Partnering & Corporate Development Events

  • 21-24
    June
    2021

    Arab Health

    Dubai, UAE

  • 9-11
    November
    2021

    CPhI Worldwide

    Milan, Italy

Get in touch

Would you like to discuss a collaboration or partnership project? Get in touch with us at partnering@labatec.ch or connect with us at one of the upcoming events.

For other enquiries, please visit our contact page.